Login
Create Account

Powerpack

Unlock full stockrow access for only $7.9/month and boost yourself as an investor.

Watchlist

Keep track of companies that you follow and research.

10 Years of Data

Full access to our data with predictions and indicators that we calculate daily.

Screener

Full access to our screener with tons of custom values and customizable email notifications.

XLS Exports

Excel export of financials and screeners you define and save.

Synopsys, Inc. SNPS

Technology — Software Infrastructure
S&P 500 Member
Indexes indicate stock being part of an index

We limit data available in the Overview Report for users who do not have Powerpack

Get access to target analyst prices, predictions, compound annual growth rates and more than four years of historical data.
Register an account and get your Powerpack now or Login

Insider Decisions

Total sells
48.17
in millions of $
Nov 25 Feb 26 May 26 Aug 26
Buy — — — — — — — — — — — —
Sell — — 1 2 — — — — 2 — 2 1
Insider Ownership
4.97%

Capital & Financial Ratios

Market Cap
73,590.00
Revenue
9,416.47
Net Income
1,075.74
Free Cash Flow
2,747.71
Net Debt
6,429.69
Current Ratio
1.34
Debt/Equity
0.32
P/E ratio
67.54
P/S ratio
7.83
P/B ratio
2.37
Past 5Y EPS Growth
33.29%
This Y EPS Growth
17.27%
Next Y EPS Growth
16.54%
Next 5Y EPS Growth
16.92%
in millions of $

Dividends

Payout Ratio
0.00
Annual Dividend Rate
—
Annual Dividend Yield
—
total individual payouts
2025 ‡‡‡
2024 ‡‡‡
2023 ‡‡‡
2022 ‡‡‡
2021 ‡‡‡
2020 ‡‡‡
predictions in italic, special payouts not included in total or ratios

Assets vs Liabilities

2023 2024 2025 Q'26
Cash 1,585.61 4,050.40 2,960.96 3,607.67
Receivables 856.66 934.47 1,505.43 1,318.75
Inventory 325.59 361.85 365.19 479.13
Other 566.00 — — —
3,430.62 6,469.67 6,012.10 6,644.34
2023 2024 2025 Q'26
Payables 1,059.91 1,163.59 1,326.21 1,480.60
ST’ Debt 86.00 — 22.12 1,020.25
Other 2,517.00 — — —
2,985.45 2,650.12 3,722.49 4,969.86
in millions of $

Compound Annual Growth

10y 5y 3y
Sales ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Cash Flow ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Earnings ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Book Value ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡

Revenue

Jan Apr Jul Oct Year
’26 2,408.80 2,275.99 2,476.82 —
—
’25 1,455.32 1,604.27 1,739.74 2,254.86
7,054.18
’24 1,510.99 1,454.71 1,525.75 1,635.99
6,127.44
’23 1,361.34 1,262.74 1,354.39 1,339.54
5,318.01
’22 1,270.26 1,279.23 1,247.77 818.46
4,615.71
’21 970.32 1,024.32 1,057.13 1,152.42
4,204.19
’20 834.38 861.33 964.13 1,025.44
3,685.28
in millions of $

Operating Cash Flow

Jan Apr Jul Oct Year
’26 856.83 628.93 812.84 —
—
’25 (67.45) 275.37 670.96 639.74
1,518.61
’24 (87.79) 476.59 455.41 562.82
1,407.03
’23 114.75 702.94 559.52 326.06
1,703.27
’22 155.74 749.96 439.69 393.51
1,738.90
’21 173.96 526.34 421.77 370.56
1,492.62
’20 9.82 379.92 399.42 202.15
991.31
in millions of $

Free Cash Flow

Jan Apr Jul Oct Year
’26 821.51 574.74 746.27 —
—
’25 (108.17) 294.06 632.36 605.19
1,423.43
’24 (128.18) 438.22 415.40 558.43
1,283.87
’23 70.63 654.45 513.41 272.96
1,511.45
’22 113.50 767.42 359.57 359.33
1,599.82
’21 145.17 509.80 398.62 343.29
1,396.88
’20 (45.85) 352.80 358.95 166.66
832.55
in millions of $

EPS

Jan Apr Jul Oct Year
’26 0.34 0.09 2.84 —
—
’25 1.89 2.21 1.50 2.39
8.04
’24 2.89 1.88 2.61 7.14
14.51
’23 1.75 1.76 2.17 2.26
7.92
’22 1.99 1.89 1.43 0.99
6.29
’21 1.03 1.24 1.27 1.28
4.81
’20 0.67 0.71 1.62 1.26
4.27

Target Price Range

High
‡‡‡‡‡
‡‡‡‡‡
Average
‡‡‡‡‡
‡‡‡‡‡
Low
‡‡‡‡‡
‡‡‡‡‡

Recommendation Rating

1.4
1
Buy
2
3
Hold
4
5
Sell
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 255.02 312.25 457.52 365.74 — — —
Low Price
‡‡‡‡ ‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 391.17 573.77 629.38 651.73 — — —
High Price
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 19,000 20,300 20,000 28,000 — — —
Employees
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 0.24 0.26 0.31 0.25 — — —
Revenue/Emp
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 4,615.71 5,318.01 6,127.44 7,054.18 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Revenue
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 80.54% 80.62% 79.68% 76.98% — — —
Gross Margin
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 1,103.45 1,305.47 1,513.86 1,393.14 ‡‡‡‡‡ — —
EBT
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 23.91% 24.55% 24.71% 19.75% ‡‡‡ ‡‡‡ ‡‡‡
EBT Margin
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 978.44 1,218.13 2,235.81 1,333.25 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Net Income
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 301.43 329.31 402.33 769.51 — — —
Depreciation
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 30.17 34.95 40.01 43.03 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Revenue/Sh
‡‡‡‡ ‡‡‡‡ ‡‡‡ ‡‡‡‡ ‡‡‡ ‡‡‡‡ 6.44 8.08 14.78 8.13 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Earnings/Sh
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 11.37 11.20 9.19 9.26 ‡‡‡‡ — —
Cash Flow/Sh
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (0.91) (1.26) (0.80) (0.58) ‡‡‡ ‡‡‡ ‡‡‡
Capex/Sh
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 10.46 9.93 8.38 8.68 — — —
Free CF/Sh
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 36.08 40.44 58.73 172.78 ‡‡‡‡‡ — —
Book Value/Sh
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 153.00 152.15 153.14 163.95 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Shares
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡ 45.43 58.10 34.80 56.24 ‡‡‡‡‡ ‡‡‡‡ ‡‡‡‡
PE Ratio
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 9.70 13.43 12.84 10.55 ‡‡‡ ‡‡‡ ‡‡‡
PS Ratio
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 8.11 11.61 8.75 2.63 ‡‡‡ ‡‡‡ ‡‡‡
PB Ratio
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 9.37 13.15 12.19 12.04 ‡‡‡‡ ‡‡‡ ‡‡‡‡
EV/Sales
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 27.05 46.27 58.19 59.66 — — —
EV/FCF
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 1,738.90 1,703.27 1,407.03 1,518.61 ‡‡‡ ‡‡‡ ‡‡‡
Op' Cash Flow
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (139.08) (191.82) (123.16) (95.17) ‡‡‡‡‡ ‡‡‡‡‡ —
Capex
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 1,599.82 1,511.45 1,283.87 1,423.43 ‡‡‡‡‡ — —
FCF
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 238.17 445.17 3,819.55 2,289.61 — — —
Working Cap'
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 74.82 104.08 15.60 13,484.52 — — —
Total Debt
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (1,490.70) (1,481.53) (4,034.80) 10,523.56 — — —
Net Debt
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 5,520.53 6,153.26 8,993.21 28,327.02 — — —
Sh' Equity
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 10.84% 12.45% 19.34% 4.35% ‡‡‡‡‡ — —
ROA
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 17.82% 17.03% 17.09% 1.47% — — —
ROIC
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 18.20% 21.07% 29.89% 7.14% ‡‡‡‡‡ — —
ROE
predictions in italic, sparklines do not include predictions

Analyst Commentary (Summary)

Synopsys (SNPS), the powerhouse behind electronic design automation software fueling the AI chip revolution, trades at a intriguing discount—3% above the lowest analyst target but 28% below the average and 49% under the high—offering growth hunters a compelling entry amid post-acquisition jitters. The $35 billion Ansys deal in early 2025 transformed it into a simulation titan, catapulting revenue projections from $6.13 billion in 2024 to $7.05 billion this year (15% YoY) and a whopping $11.85 billion by 2028 (20%+ CAGR), driven by Nvidia’s AI rush and semis demand. Yet, this bold move spiked debt to $13.5 billion, triggered a 42% stock plunge to $366 lows, and diluted EPS to $8.13 in 2025 before rebounding.

Fundamentals shine through the volatility: Gross margins at 76-80%, ROE peaking at 30% pre-deal, and free cash flow per share holding firm above $8, underscoring a sticky moat in chip design. Valuation multiples like 12.8x PS and 50x+ PE reflect a premium, but projections show EV/Sales dipping to 7.3x by 2028 as scale kicks in. Insiders leaned sellers ($44M out vs. $149k in), though one director’s timely buy signals conviction at dips.

AI tailwinds from Blackwell and MI300 chips position SNPS for EPS surges to $8.91 by 2028 and 28% mean-target upside, but watch integration risks, China tensions, and Q1 2026 earnings for synergies. For retail investors eyeing the semis wave, it’s a high-octane bet—growth at a leverage premium worth the thrill? Dive into the full breakdown.

Read full commentary →

Synopsys, Inc. (SNPS) Latest News

News by impact score

Fine-tune

16 Sep

4 www.tikr.com, 1:05 PM
Synopsys beat earnings estimates for four consecutive quarters, showing the Ansys acquisition is delivering positive results. Four straight earnings beats plus successful Ansys integration point to sustained outperformance and strategic momentum.

3 www.trefis.com, 3:43 PM
Cadence must sustain elevated growth rates and margins to support its valuation amid competition from Synopsys in the EDA sector. Cadence valuation analysis may shift relative investor views on Synopsys competitive positioning.

12 Sep

4 247wallst.com, 11:00 AM
Synopsys is predicted to become the next major winner in artificial intelligence. AI leadership prediction can significantly boost Synopsys investor sentiment and valuation trajectory.

11 Sep

3 www.trefis.com, 11:45 AM
Synopsys shares trade at a discount as AI evaluates its software capabilities. AI scrutiny of Synopsys software could moderately affect its positioning in semiconductor design tools.

10 Sep

3 www.barchart.com, 4:09 PM
Wells Fargo upgraded Synopsys (SNPS) stock, citing factors that may influence investor views on the company's performance and positioning. Analyst upgrade can lift short-term sentiment and trading but does not alter Synopsys core operations or long-term trajectory.

8 Sep

3 , 8:46 AM
Morgan Stanley upgraded Synopsys (SNPS) while shifting to a selective stance on chip stocks. Analyst upgrade lifts near-term sentiment for SNPS yet sector selectivity caps broader trajectory shifts.

6 Sep

3 www.barchart.com, 3:30 PM
Layoffs at Synopsys prompt trading strategies for SNPS stock amid workforce cuts and potential market reactions. Layoffs signal operational adjustments that may influence short-term sentiment and stock movement but lack broader strategic shifts.

4 Sep

3 247wallst.com, 9:29 AM
Synopsys shares fell 11% year to date while Wall Street forecasts project a 50% gain over the next 12 months. Analyst upside targets may lift near-term investor sentiment and share price without altering core operations.

3 Sep

3 www.trefis.com, 6:47 PM
SNPS core engine growth significantly trailed overall revenue expansion. Slower core engine growth signals potential weakness in primary operations.

3 247wallst.com, 9:22 AM
Marvell Technology recognizes Synopsys as a major competitive threat in semiconductors and chip design, underscoring pressure on Synopsys' market position and future growth prospects. Recognition of Synopsys as a threat by Marvell highlights competitive dynamics likely to exert moderate influence on Synopsys' trajectory.

1 Sep

3 247wallst.com, 10:00 AM
SNPS faces potential undervaluation as market overlooks its AI chip-design strengths, positioning the firm for stronger future growth amid rising semiconductor demand. Bullish AI angle may lift short-term sentiment without altering core business trajectory.

31 Aug

4 transcript www.fool.com, 9:50 AM
Synopsys (SNPS) held its Q3 2026 earnings call covering quarterly financial results, revenue figures, profitability metrics, and forward business guidance. Earnings call delivers financial results and outlook that directly shape investor views and near-term stock movement.

3 www.trefis.com, 5:23 PM
Synopsys stock upside now hinges on payment collection methods and revenue strategies. Payment approaches shape Synopsys revenue and market valuation.

28 Aug

4 , 10:44 PM
Synopsys targets 42% non-GAAP operating margin with questions raised on profitability distortion from the Ansys acquisition. Ansys acquisition introduces major questions on sustainability of Synopsys targeted non-GAAP margins.

4 , 5:08 AM
Synopsys beat earnings expectations and raised its outlook, shifting investor focus back to the company's valuation. Earnings beat combined with higher guidance typically drives meaningful shifts in stock performance and sentiment.

27 Aug

4 , 7:13 PM
Synopsys raised FY26 guidance, driving a 16.8% stock gain despite mixed profit trends and raising questions on whether the bull case has changed. FY26 guidance increase signals materially stronger future financial performance and shifts investor expectations for Synopsys.

4 , 1:27 PM
Synopsys Q3 earnings call highlights EDA acceleration and raised outlook. Raised outlook signals stronger growth trajectory in core EDA markets.

4 qz.com, 1:25 PM
Synopsys beat Q3 2026 earnings estimates and raised full-year guidance. Earnings beat combined with raised guidance signals strong momentum that typically drives notable stock gains and shifts investor outlook.

4 , 11:11 AM
Synopsys Q3 earnings beat estimates driven by EDA and Ansys strength. Q3 earnings beat with EDA and Ansys strength signals significant positive effect on Synopsys trajectory and investor sentiment.

4 , 9:56 AM
Elliott takes multibillion-dollar stake in Synopsys to close valuation discount versus peers. Activist multibillion-dollar position signals pressure for strategic actions that can materially lift SNPS valuation and performance.

4 , 8:12 AM
Synopsys raised its annual outlook, attributing the increase to surging demand from rising AI complexity. Raised annual outlook tied to AI demand points to major growth acceleration and stronger market positioning.

4 investorshub.advfn.com, 6:10 AM
Synopsys exceeded Q3 forecasts and raised 2026 guidance due to strengthening AI demand. Earnings beat combined with raised guidance signals strong AI-driven growth and improved financial outlook.

4 , 1:01 AM
Synopsys reported record Q3 2026 revenue and raised its forward guidance. Record revenue and raised guidance signal strong growth that can lift valuation and investor sentiment.

3 , 10:33 AM
Synopsys receives upgrade on expected FY27 growth rebound and stronger chip-design demand. Analyst upgrade signals expected FY27 rebound from rising chip-design demand.

3 transcript app.moby.co, 8:30 AM
Synopsys, Inc. released Q3 2026 earnings call details covering financial results and outlook. Q3 2026 earnings provide financial metrics and guidance that may shift near-term investor views.

26 Aug

3 www.marketbeat.com, 7:04 PM
Synopsys Q3 earnings call highlighted financial results and strategic updates for the company. Quarterly earnings updates typically affect stock price movements and investor sentiment.

3 , 5:30 PM
Synopsys Q3 earnings include key metrics such as revenue and EPS compared directly to consensus estimates, showing quarterly performance against analyst forecasts. Standard Q3 earnings metrics versus estimates can shift near-term sentiment and valuation but rarely alter long-term company trajectory.

3 , 5:20 PM
Synopsys posted Q3 earnings and revenues above analyst estimates. Quarterly earnings beats provide short-term sentiment lift but rarely shift long-term trajectory.

3 , 4:49 PM
Synopsys shares fell after the company beat earnings expectations and raised its 2026 outlook. Earnings beat and raised outlook produce moderate effects on performance and sentiment despite share decline.

3 , 4:05 PM
Synopsys posted financial results for the third quarter of fiscal year 2026. Quarterly earnings releases provide financial metrics that can influence near-term stock valuation and sentiment.
© 2016–2026 stockrow.com Terms and Conditions Indicators Contact Us